Drug Crackdown in Himachal: Private Clinics, Chemists and Quacks Under Investigation
As Himachal Pradesh intensifies its fight against drug abuse, the spotlight has now shifted beyond traditional drug traffickers to private clinics, chemists and unauthorised healthcare providers suspected of enabling access to addictive medicines.
A statewide inspection drive conducted by joint teams of the Special Task Force (STF), district police, Health Department and Drug Control authorities has uncovered alarming irregularities in more than 300 clinics and healthcare establishments. Officials report that a significant number of these centres were allegedly prescribing restricted and habit-forming medicines to young people under the guise of treatment, raising concerns about the growing misuse of controlled drugs.
Investigators believe that medicines meant for genuine medical needs may be finding their way into illegal drug networks. The probe is focused on commonly misused drugs such as Tramadol, Alprazolam, Buprenorphine and Codeine, which are subject to strict regulations due to their addictive potential.
During the inspections, authorities examined medical licences, practitioner registrations, drug storage facilities, purchase and sale records, and outpatient department (OPD) registers. In several cases, officials are investigating suspected discrepancies in records, including allegations that medicine stocks were obtained using fabricated or manipulated patient data.
The highest number of suspected violations has reportedly been detected in Kangra, Solan and Sirmaur districts, where detailed investigations are now underway. Authorities are also examining whether controlled medicines were supplied beyond prescribed limits and subsequently diverted into the illicit drug trade.
The STF has expanded its investigation to trace the entire supply chain, looking for possible links between drug traffickers, private clinics, chemists and other individuals involved in the distribution network. Officials have warned that strict legal action will be taken if evidence of collusion or deliberate diversion of medicines is established.
As part of the broader campaign, de-addiction and rehabilitation centres are also being reviewed to ensure compliance with regulations and to prevent any misuse of controlled substances.
Authorities have clarified that the ongoing action is not directed against all private healthcare providers. Instead, the objective is to identify regulatory violations, unauthorised medical practices and any misuse of medicines that could be fuelling substance abuse in the state.
